Acumen Pharmaceuticals, INC. (ABOS) — 10-Q Filings

All 10-Q filings from Acumen Pharmaceuticals, INC.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Acumen's Losses Widen on Soaring R&D as Alzheimer's Trial Progresses — Nov 12, 2025 Risk: high
Acumen Pharmaceuticals, Inc. (ABOS) reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $96.2 million, up from $6
10-Q Filing — Aug 12, 2025
Acumen Pharmaceuticals Files Q1 2025 10-Q — May 13, 2025 Risk: low
Acumen Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The company, incorporated in Delaware, operates in the biological products sec
Acumen Pharmaceuticals Files Q3 2024 10-Q — Nov 12, 2024 Risk: medium
Acumen Pharmaceuticals, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported financial results for the third quarter and the first
Acumen Pharmaceuticals Files Q2 2024 10-Q — Aug 13, 2024 Risk: medium
Acumen Pharmaceuticals, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results for the second quarter and the first six
Acumen Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — May 14, 2024 Risk: low
Acumen Pharmaceuticals, Inc. (ABOS) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Acumen Pharmaceuticals, Inc. filed a 10-Q report for the perio

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX